Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology

Position Summary For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market positioning. Specifically, evidence must be generated and maintained throughout the product lifecycle as the standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements.…